Summary
GSK is set to cut jobs as part of a £1.9bn cost-cutting plan, which will fund a £400m investment in UK life sciences and a new R&D center in Cambridge. The pharmaceutical company will move over 1,000 scientists to its new Cambridge site and close its Stevenage R&D facility by 2029.